Unique ID issued by UMIN | UMIN000015480 |
---|---|
Receipt number | R000017993 |
Scientific Title | Effects of mountain ginseng(Panax ginseng C.A. Meyer) on the improvement for male sexual function and in fatigue for 12 weeks. |
Date of disclosure of the study information | 2014/10/20 |
Last modified on | 2015/03/10 11:38:40 |
Effects of mountain ginseng(Panax ginseng C.A. Meyer) on the improvement for male sexual function and in fatigue for 12 weeks.
Effects of mountain ginseng(Panax ginseng C.A. Meyer) on the improvement for male sexual function and in fatigue for 12 weeks.
Effects of mountain ginseng(Panax ginseng C.A. Meyer) on the improvement for male sexual function and in fatigue for 12 weeks.
Effects of mountain ginseng(Panax ginseng C.A. Meyer) on the improvement for male sexual function and in fatigue for 12 weeks.
Japan |
Erectile Dysfunction
Medicine in general | Urology | Adult |
Others
NO
To investigate the effects of tissue-cultured mountain ginseng (Panax ginseng C.A. Meyer) on male with erectile dysfunction and fatigue.
Safety,Efficacy
International Index of Erectile Function and Aging Male Symptoms rating scale.
Physical examinations
Blood test
Urine test
Interventional
Parallel
Randomized
Cluster
Double blind -all involved are blinded
Placebo
NO
3
Treatment
Food |
Duration: 12weeks
Test material: Placebo
4 capsules per day
Duration: 12weeks
Test material: Mountain ginseng 200mg
4 capsules per day (200mg/day)
Duration: 12weeks
Test material: Mountain ginseng 600mg
4 capsules per day (600mg/day)
35 | years-old | <= |
70 | years-old | >= |
Male
(1) Males between the age of 35 and 70.
(2) Males who have the sexual decline.
(3) Subjects who answered IIEF5(International Index of Erectile Function 5) score more than /equal 21.
(4) Subjects who can make self-judgment and are voluntarily giving written informed consent.
(1) Subjects who are allergic to food related to the test material of this trial.
(2) Subjects who have previous medical history of the serious diseases (heart, liver, kidney, blood, digestive system,metabolism system)
(3) Subjects who are under treatment for hypertension, or who untreated hypertension (not less than level 2).
(4) Subjects who contract or are under treatment for diseases of prostatic.
(5) Subjects who are under treatment for diabetes.
(6) Subjects who are judged as inappropriate for this study by physicians.
45
1st name | |
Middle name | |
Last name | Katsuhisa SAKANO |
CPCC Company Limited
Clinical Research Planning Department
4F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan
03-5927-3112
cpcc-contact@cpcc.co.jp
1st name | |
Middle name | |
Last name | Makoto ICHINOHE |
CPCC Company Limited
Plan sales department
4F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan
03-5927-3112
cpcc-contact@cpcc.co.jp
CPCC Company Limited
Omnica Co., Ltd
Profit organization
NO
チヨダパラメディカルケアクリニック(東京都)
2014 | Year | 10 | Month | 20 | Day |
Unpublished
Completed
2014 | Year | 10 | Month | 09 | Day |
2014 | Year | 10 | Month | 24 | Day |
2014 | Year | 10 | Month | 20 | Day |
2015 | Year | 03 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017993
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |